Skip to Content

Olopatadine ophthalmic Pregnancy and Breastfeeding Warnings

Olopatadine ophthalmic is also known as: Pataday, Patanol, Pazeo

Olopatadine ophthalmic Pregnancy Warnings

Olopatadine ophthalmic solution has been assigned to pregnancy category C by the FDA. Animal studies have failed to reveal evidence of teratogenicity; however, fetolethality increased in rats treated with extremely high oral doses (62,500 times the human dose) . There are no controlled data in human pregnancy. Olopatadine is only recommended for use during pregnancy when benefit outweighs risk.

See references

Olopatadine ophthalmic Breastfeeding Warnings

There are no data on the excretion of olopatadine ophthalmic solution into human milk. However, due to minimal systemic absorption, it is not expected that clinically significant amounts would be excreted into breast milk. The manufacturer recommends that caution be used when administering olopatadine to nursing women.

See references

References for pregnancy information

  1. "Product Information. Patanol (olopatadine ophthalmic)." Alcon Laboratories Inc, Fort Worth, TX.

References for breastfeeding information

  1. "Product Information. Patanol (olopatadine ophthalmic)." Alcon Laboratories Inc, Fort Worth, TX.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.